EcoDrugPlus

Ensembl ID : WBGene00234010
Gene Symbol: WBGENE00234010
6 External references
73 Possible Orthologues:

Ensembl ID : WBGene00234014
Gene Symbol: WBGENE00234014
4 External references
73 Possible Orthologues:

Ensembl ID : WBGene00234017
Gene Symbol: WBGENE00234017
5 External references
85 Possible Orthologues:

Ensembl ID : WBGene00234018
Gene Symbol: WBGENE00234018
6 External references
83 Possible Orthologues:

Ensembl ID : WBGene00234029
Gene Symbol: WBGENE00234029
6 External references
100 Possible Orthologues:

Ensembl ID : WBGene00234032
Gene Symbol: WBGENE00234032
4 External references
111 Possible Orthologues:

Ensembl ID : WBGene00234035
Gene Symbol: WBGENE00234035
6 External references
122 Possible Orthologues:

Ensembl ID : WBGene00234040
Gene Symbol: WBGENE00234040
4 External references
111 Possible Orthologues:

Ensembl ID : WBGene00234044
Gene Symbol: WBGENE00234044
4 External references
198 Possible Orthologues:

Ensembl ID : WBGene00234117
Gene Symbol: WBGENE00234117
6 External references
73 Possible Orthologues:

Ensembl ID : WBGene00234120
Gene Symbol: WBGENE00234120
4 External references
70 Possible Orthologues:

Ensembl ID : WBGene00234130
Gene Symbol: WBGENE00234130
6 External references
72 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).